Advertisement
Advertisement

Nominations for New Physician/Clinician Members of the DHHS Panel on Pediatric Antiretroviral Therapy and Management Guidelines

December 5, 2011

The Department of Health and Human Services (HHS) Panel on Pediatric Antiretroviral Therapy and Management Guidelines (the Pediatric Guidelines Panel) is accepting nominations for new members with clinical research and/or practice expertise in management of HIV infection in children. The Panel anticipates one vacancy for a 3-year term beginning January 2012, with potential for reappointment for a second term.

The Pediatric Guidelines Panel is a working group of the Office of AIDS Research Advisory Council (OARAC) of the National Institutes of Health (NIH). The Panel is composed of approximately 25 members who are clinicians, researchers, academicians, and HHS representatives with expertise in pediatric HIV management, and community representatives with knowledge of HIV infection in children. The Panel meets monthly via teleconferencing and on occasion in person to review and critically evaluate emerging scientific data relating to antiretroviral therapy in infants and children. The members actively engage in the preparation and update of the "Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection." The document is widely used by HIV practitioners and researchers in the United States. (To view the latest version of the guidelines visit the AIDSinfo clinical guidelines portal.)

Panel members are not compensated for their time commitment and travel support is not provided for participation.

Advertisement
The Panel is currently seeking nominations for new members with expertise in pediatric HIV clinical trials, outcome research, and/or clinical practice who will work with other Panel members in critically evaluating new information and preparing revisions to the pediatric antiretroviral guidelines. The candidates should have scientific expertise in pediatric/adolescent HIV infection as evidenced by meaningful contributions to peer review journals related to pediatric HIV infection; participation in pediatric clinical research networks; receipt of NIH funding related to pediatric HIV infection as principal or co-principal investigator; clinical expertise in pediatric HIV infection as evidenced by more than 5 years experience in the field of HIV and ongoing participation in the clinical care of HIV-infected children/adolescents; and recognition of clinical expertise by peers (such as certification by HIV Medical Association/Infectious Disease Society of America, membership on HIV-related committees of the American Academy of Pediatrics, consultant to Centers for Disease Control and Prevention or World Health Organization on pediatric HIV-related issues). Because these guidelines focus on pediatric antiretroviral management in the United States, candidates must be from the United States. Candidates should be willing to dedicate the necessary time to participate on the Working Group -- a minimum of monthly conference calls and willingness to actively write revisions. The successful candidates shall serve a 3-year term starting in January 2012.

Please include with nomination the candidate's curriculum vitae and a letter of nomination or letter of interest outlining what qualities and contributions the candidate may bring to the Panel. The deadline for nominations is December 30, 2011. Please e-mail nominations to Lynne M. Mofenson, M.D., Panel Executive Secretary, at LM65D@nih.gov or Lynne.Mofenson@nih.hhs.gov. or send to the following address: Lynne M. Mofenson, M.D., National Institute of Child Health and Human Development, National Institutes of Health, 6100 Executive Boulevard, Room 4B11, Rockville, MD 20852 (Fax: 301-496-8678).




This article was provided by AIDSinfo. Visit the AIDSinfo website to find out more about their activities and publications.
 

No comments have been made.
 

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:

Advertisement

The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.